Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Granutec

This article was originally published in The Tan Sheet

Executive Summary

Granutec: Agrees to stop using Tylenol gelcap red-and-yellow color scheme for private-label products in a settlement with McNeil. Under the agreement, "in lieu of a recall, Granutec will change the colors of its encapsulated generic acetaminophen, as well as its generic versions of the Tylenol PM and Mylanta gelcaps," McNeil announced on April 19. Granutec also will be prohibited from imitating the colors of "all current and future multi-colored OTC gelatin products" sold by J&J subsidiaries. The generics company will pay McNeil $250,000 for legal fees. McNeil won a preliminary injunction against the Novopharm subsidiary in December. The order, and a later modifying provision, instructed Granutec to initiate a customer recall for all products resembling Tylenol gelcaps ("The Tan Sheet" Jan. 15, p. 3)...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085010

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel